Back to News
Market Impact: 0.08
SAN FRANCISCO HEALTH PLAN EARNS HISTORIC 4.5-STAR RATING IN 2026 NCQA HEALTH PLAN RATINGS
Source: PR Newswire
Healthcare & Biotech
San Francisco Health Plan received its first-ever 4.5-star rating in the 2026 NCQA Health Plan Ratings as it approaches 30 years of community service. The achievement signals improved healthcare-plan quality and member-service performance, but is unlikely to have material public-market implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
More News
- Wells Fargo sees improvement in a key metric — plus, Lilly gets praise beyond GLP-1s
- Inside South Korea’s university programs offering a direct route to Samsung and SK Hynix
- A sharp stock market decline could lie around the corner, Wells Fargo warns
- Why is Vera Therapeutics stock reversing its premarket gains?
- H.C. Wainwright raises Scholar Rock stock price target on FDA approval
- Tempest Therapeutics stock surges on Senlang CAR-T deal